Alcohol use disorder (AUD) remains a major public health challenge in the United States, contributing to more than 170,000 ...

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies. While more research is needed, preclinical and ...

Baclofen, a GABA B receptor agonist traditionally used as a muscle relaxant, has emerged as a promising pharmacological option in the management of Alcohol Use Disorder (AUD). By modulating inhibitory ...

Pemvidutide is a novel, peptide-based GLP-1/glucagon dual receptor agonist. The Food and Drug Administration (FDA) has granted Fast Track designation to pemvidutide for the treatment of alcohol use ...

The US Surgeon General’s Advisory in 2025 on alcohol recommended updating the warning label on alcohol-containing beverages to include cancer, counseling patients about alcohol as a cancer risk factor ...

Please provide your email address to receive an email when new articles are posted on . There are limited numbers of FDA-approved medications to treat alcohol and substance use disorders. Preclinical ...

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacologic therapies. While more research is needed, preclinical and ...

As weight-loss drugs like Ozempic revolutionize weight loss, scientists hope they may also be life-changing for alcohol addiction. The drugs are one of several approaches doctors and psychiatrists ...

First, the grim statistics on alcohol use disorder (AUD), the challenging and baffling condition formerly known as alcoholism. At least 95,000 people (approximately 68,000 men and 27,000 women) die ...

Please provide your email address to receive an email when new articles are posted on . Pharmacotherapy appears to be underused in alcohol use disorder, especially among those with related liver ...

Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...

Starting oral or injectable naltrexone at hospital discharge reduced heavy drinking in patients with alcohol use disorder. The hospital is an opportune setting for identifying and treating patients ...